BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Biologics Manufacturing Market Size to Hit USD 162.51 Billion by 2034, Growing at an Extraordinary 17.1% CAGR

  November 20, 2025

   · 

  1 min read
• Press Releases

  Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)

  November 20, 2025

   · 

  9 min read
• Press Releases

  Concept Life Sciences Presents New Data Advancing Neuroinflammation and Neurodegeneration Research at Neuroscience 2025

  November 20, 2025

   · 

  4 min read
• Press Releases

  Cognizant selected by CEPI to transform enterprise architecture and core ERP operations

  November 20, 2025

   · 

  2 min read
• Press Releases

  AAV Gene Therapy Market Size Worth USD 23,546.27 Million by 2034

  November 20, 2025

   · 

  1 min read
• 

  C-suite

  Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T

  The drugmaker’s dominance of the obesity market is fueling predictions that years of growth lie ahead.

  November 20, 2025

   · 

  5 min read

   · 

  Nick Paul Taylor
• 

  Approvals

  FDA Hands Regeneron Two Eylea HD Nods in One Day

  The approvals come as a pleasant surprise for Regeneron, analysts say, helping bolster the overall product profile of high-dose Eylea despite outstanding manufacturing concerns.

  November 20, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Lung cancer

  Bayer Wins Lung Cancer Accelerated Approval for Kinase Inhibitor

  The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 blocker for non-small cell lung cancer.

  November 20, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• Press Releases

  DNA Synthesis Market Size to Lead USD 30,320 Million by 2034

  November 20, 2025

   · 

  1 min read
• 

  Funding

  Aspen’s $115M Series C Opens Doors to Late-Stage Development for Parkinson’s Program

  Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy to the market.

  November 20, 2025

   · 

  1 min read

   · 

  Tristan Manalac